Exploring the combined neuroprotective effects of resveratrol and hesperidin in a scopolamine-induced rat model of cognitive impairment

被引:0
作者
Bhattacharjee, Bedanta [1 ,2 ]
Shakya, Anshul [1 ]
Shivavedi, Naveen [3 ]
Sahu, Ram Kumar [4 ]
Sandhanam, K. [5 ]
机构
[1] Dibrugarh Univ, Fac Sci & Engn, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India
[2] Girijananda Chowdhury Univ, Sch Pharmaceut Sci, Tezpur Campus, Tezpur 784501, Assam, India
[3] Shri Ram Inst Technol, Fac Pharm, Jabalpur 482002, Madhya Pradesh, India
[4] Hemvati Nandan Bahuguna Garhwal Univ, Dept Pharmaceut Sci, Chauras Campus, Tehri Garhwal, Uttarakhand, India
[5] SRMIST, SRM Coll Pharm, Dept Pharmacol, Chennai 603203, India
关键词
Alzheimer's; Scopolamine; Resveratrol; Hesperidin; TNF-alpha; Acetylcholinesterase; COMORBID DEPRESSION; DEHYDROGENASE; HIPPOCAMPUS; PROTEINS; THERAPY; ASSAY;
D O I
10.1016/j.neuroscience.2025.05.302
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The occurrence of cognitive impairment in normal aging and sporadic Alzheimer's disease is linked to oxidative stress. Resveratrol, a polyphenolic molecule, and hesperidin, a flavanone glycoside have exhibited powerful antioxidant and neuroprotective effects. The present study was designed to explore the neurotherapeutic potential of combination between resveratrol and hesperidin as preventative herbal remedies to inhibit oxidative stress and cholinergic and mitochondrial dysfunction in scopolamine-induced cognitive impairments in rats. Resveratrol (20 mg/kg, p.o.), hesperidin (20 mg/kg, p.o.), and its combination were administered orally up to 21 days. Cognitive impairment was induced by intraperitoneal injection of scopolamine (1 mg/kg, i.p.) to rats for 5 days (15th, 16th, 17th, 18th, and 19th). Learning and memory function in rats were appraised by using the Morris water maze. Subsequently, the content of oxidative-nitrosative stress parameters, the activity of acetylcholinesterase (AChE), electron transport chain complexes, brain-derived neurotrophic factor (BDNF), and proinflammatory cytokines mediators (TNF-alpha and IL-6) in hippocampus brain areas of rats were measured. Scopolamine treatment significantly produced learning and memory impairment, oxidative-nitrosative stress, cholinergic dysfunction, mitochondrial deficit, reduced BDNF, and increased TNF-alpha and IL-6 levels. Whereas, resveratrol and hesperidin combination therapy effectively improved brain anti-oxidant status, lowered brain mitochondrial impairments, and neuro-inflammation in rats as compared to mono-therapy. Our findings demonstrated that the resveratrol and hesperidin combination group showed excellent anti-cognitive impairment properties compared to single therapy. The combination therapy exhibited a favorable effect in suppressing scopolamine-induced cognitive impairment, either additively, synergistically, or through distinct molecular pathways.
引用
收藏
页码:54 / 68
页数:15
相关论文
共 84 条
[1]   Combined resveratrol and vitamin D treatment ameliorate inflammation-related liver fibrosis, ER stress, and apoptosis in a high-fructose diet/streptozotocin-induced T2DM model [J].
Anapali, Merve ;
Kaya-Dagistanli, Fatma ;
Akdemir, Ayse Seda ;
Aydemir, Duygu ;
Ulusu, Nuriye Nuray ;
Ulutin, Turgut ;
Uysal, Omer ;
Tanriverdi, Gamze ;
Ozturk, Melek .
HISTOCHEMISTRY AND CELL BIOLOGY, 2022, 158 (03) :279-296
[2]   Natural products in drug discovery: advances and opportunities [J].
Atanasov, Atanas G. ;
Zotchev, Sergey B. ;
Dirsch, Verena M. ;
Supuran, Claudiu T. .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (03) :200-216
[3]  
Bansal K., 2023, Current Molecular Medicine
[4]  
Bashir D.J., 2023, ) Magnoflorine-Loaded Chitosan Collagen Nanocapsules Ameliorate Cognitive Deficit in Scopolamine-Induced Alzheimer's Disease-like Conditions in a Rat Model by Downregulating IL-1Beta, IL-6, TNF-, and Oxidative Stress and Upregulating Brain-Derived Neurotrophic Factor and DCX Expressions
[5]  
Been L.E., 2023, bioRxiv
[6]   Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe [J].
Boccardi, Marina ;
Monsch, Andreas U. ;
Ferrari, Clarissa ;
Altomare, Daniele ;
Berres, Manfred ;
Bos, Isabelle ;
Buchmann, Andreas ;
Cerami, Chiara ;
Didic, Mira ;
Festari, Cristina ;
Nicolosi, Valentina ;
Sacco, Leonardo ;
Aerts, Liesbeth ;
Albanese, Emiliano ;
Annoni, Jean-Marie ;
Ballhausen, Nicola ;
Chicherio, Christian ;
Demonet, Jean-Francois ;
Descloux, Virginie ;
Diener, Suzie ;
Ferreira, Daniel ;
Georges, Jean ;
Gietl, Anton ;
Girtler, Nicola ;
Kilimann, Ingo ;
Kloppel, Stefan ;
Kustyniuk, Nicole ;
Mecocci, Patrizia ;
Mella, Nathalie ;
Pigliautile, Martina ;
Seeher, Katrin ;
Shirk, Steven D. ;
Toraldo, Alessio ;
Brioschi-Guevara, Andrea ;
Chan, Kwun C. G. ;
Crane, Paul K. ;
Dodich, Alessandra ;
Grazia, Alice ;
Kochan, Nicole A. ;
de Oliveira, Fabricio Ferreira ;
Nobili, Flavio ;
Kukull, Walter ;
Peters, Oliver ;
Ramakers, Inez ;
Sachdev, Perminder S. ;
Teipel, Stefan ;
Visser, Pieter Jelle ;
Wagner, Michael ;
Weintraub, Sandra ;
Westman, Eric .
ALZHEIMERS & DEMENTIA, 2022, 18 (01) :29-42
[7]   Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer's Disease [J].
Chakraborty, Biswajit ;
Mukerjee, Nobendu ;
Maitra, Swastika ;
Zehravi, Mehrukh ;
Mukherjee, Dattatreya ;
Ghosh, Arabinda ;
Massoud, Ehab El Sayed ;
Rahman, Md. Habibur .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
[8]   Resveratrol in experimental Alzheimer's disease models: A systematic review of preclinical studies [J].
Chen, Jia-Yue ;
Zhu, Qi ;
Zhang, Shuang ;
OuYang, Defang ;
Lu, Jia-Hong .
PHARMACOLOGICAL RESEARCH, 2019, 150
[9]   Neuroprotective Natural Products for Alzheimer's Disease [J].
Chen, Xin ;
Drew, Joshua ;
Berney, Wren ;
Lei, Wei .
CELLS, 2021, 10 (06)
[10]  
Choi Yewon, 2015, Translational and Clinical Pharmacology, V23, P26